Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection

Journal of Controlled Release

Volumn 263, Issue , 2017, Pages 185-191

  Zhang, Yue ^a   Zhang, Jianhua ^a,b   Chen, Wansong ^a,c   Angsantikul, Pavimol ^a   Spiekermann, Kevin A ^a   Fang, Ronnie H ^a   Gao, Weiwei ^a   Zhang, Liangfang ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b TIANJIN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antibiotic delivery; Cell membrane coating; Detoxification; Nanomedicine; Staph infection

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BLOOD; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; COVALENT BONDS; CYTOLOGY; DETOXIFICATION; GELATION; MACROPHAGES; MEDICAL NANOTECHNOLOGY; STAPHYLOCOCCUS AUREUS; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY;

BACTERIAL INHIBITION; ERYTHROCYTE MEMBRANE; EXTRACELLULAR ENVIRONMENTS; MEMBRANE COATINGS; MEMBRANE VESICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; REDUCING ENVIRONMENT; STAPH INFECTION;

NANOSTRUCTURED MATERIALS;

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; NANOGEL; NANOPARTICLE; UNCLASSIFIED DRUG; VANCOMYCIN; HEMOLYSIN; STAPHYLOCOCCAL ALPHA-TOXIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG RELEASE; ERYTHROCYTE MEMBRANE; GELATION; MACROPHAGE; MEMBRANE VESICLE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NANOENCAPSULATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; DRUG EFFECT; GEL; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; DRUG LIBERATION; ERYTHROCYTE MEMBRANE; GELS; HEMOLYSIN PROTEINS; MACROPHAGES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE, INBRED ICR; NANOPARTICLES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 85009815189     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2017.01.016     Document Type: Article

References (37)

1. Foster, T.J., Geoghegan, J.A., Ganesh, V.K., Hook, M., Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 12 (2014), 49–62.
2. Pantosti, A., Methicillin-resistant Staphylococcus aureus associated with animals and its relevance to human health. Front. Microbiol., 3, 2012, 127.
3. Chambers, H.F., Deleo, F.R., Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7 (2009), 629–641.
4. Yoong, P., Pier, G.B., Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 2241–2246.
5. Edwards, B., Andini, R., Esposito, S., Grossi, P., Lew, D., Mazzei, T., Novelli, A., Soriano, A., Gould, I.M., Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: where are we now?. J. Glob. Antimicrob. Resist. 2 (2014), 133–140.
6. Vuong, C., Yeh, A.J., Cheung, G.Y.C., Otto, M., Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert Opin. Invest. Drugs 25 (2016), 73–93.
7. Tirilomis, T., Daptomycin and its immunomodulatory effect consequences for antibiotic treatment of methicillin-resistant Staphylococcus aureus wound infections after heart surgery. Front. Immunol., 5, 2014, 97.
8. Burke, S.L., Rose, W.E., New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections. Expert. Opin. Pharmacother. 15 (2014), 483–491.
9. Kumar, K., Chopra, S., New drugs for methicillin-resistant Staphylococcus aureus: an update. J. Antimicrob. Chemother. 68 (2013), 1465–1470.
10. Gardete, S., Tomasz, A., Mechanisms of vancomycin resistance in Staphylococcus aureus. J. Clin. Invest. 124 (2014), 2836–2840.
11. Peacock, S.J., Paterson, G.K., Mechanisms of methicillin resistance in Staphylococcus aureus. Annu. Rev. Biochem. 84 (2015), 577–601.
12. Singer, A.J., Talan, D.A., Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 370 (2014), 1039–1047.
13. Brauner, A., Fridman, O., Gefen, O., Balaban, N.Q., Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14 (2016), 320–330.
14. Hu, C.M.J., Zhang, L., Nanotoxoid vaccines. Nano Today 9 (2014), 401–404.
15. Greenlee-Wacker, M., DeLeo, F.R., Nauseef, W.M., How methicillin-resistant Staphylococcus aureus evade neutrophil killing. Curr. Opin. Hematol. 22 (2015), 30–35.
16. Hu, C.M.J., Fang, R.H., Copp, J., Luk, B.T., Zhang, L., A biomimetic nanosponge that absorbs pore-forming toxins. Nat. Nanotechnol. 8 (2013), 336–340.
17. Hu, C.M.J., Fang, R.H., Luk, B.T., Zhang, L., Nanoparticle-detained toxins for safe and effective vaccination. Nat. Nanotechnol. 8 (2013), 933–938.
18. Wang, F., Gao, W., Thamphiwatana, S., Luk, B.T., Angsantikul, P., Zhang, Q.Z., Hu, C.M.J., Fang, R.H., Copp, J.A., Pornpattananangkul, D., Lu, W., Zhang, L., Hydrogel retaining toxin-absorbing nanosponges for local treatment of methicillin-resistant Staphylococcus aureus infection. Adv. Mater. 27 (2015), 3437–3443.
19. Foster, T.J., Immune evasion by staphylococci. Nat. Rev. Microbiol. 3 (2005), 948–958.
20. Lehar, S.M., Pillow, T., Xu, M., Staben, L., Kajihara, K.K., Andlen, R.V., DePalatis, L., Raab, H., Hazenbos, W.L., Morisaki, J.H., Kim, J., Park, S., Darwish, M., Lee, B.C., Hernandez, H., Loyet, K.M., Lupardus, P., Fong, R.N., Yan, D.H., Halouni, C.C., Luis, E., Khalfin, Y., Plise, E., Heong, J.C., Lyssikatos, J.P., Strandh, M., Koefoed, K., Andersen, P.S., Flygare, J.A., Tan, M.W., Brown, E.J., Ariathasan, S.M., Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 527 (2015), 323–328.
21. Kubica, M., Guzik, K., Koziel, J., Zarebski, M., Richter, W., Gajkowska, B., Golda, A., Maciag-Gudowska, A., Brix, K., Shaw, L., Foster, T., Potempa, J., A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One, 3, 2008, e1409.
22. Kim, H.K., Thammavongsa, V., Schneewind, O., Missiakas, D., Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr. Opin. Microbiol. 15 (2012), 92–99.
23. Maya, S., Indulekha, S., Sukhithasri, V., Smitha, K.T., Nair, S.V., Jayakumar, R., Biswas, R., Efficacy of tetracycline encapsulated o-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int. J. Biol. Macromol. 51 (2012), 392–399.
24. Kamaruzzaman, N.F., Firdessa, R., Good, L., Bactericidal effects of polyhexamethylene biguanide against intracellular Staphylococcus aureus EMRSA-15 and USA 300. J. Antimicrob. Chemother. 71 (2016), 1252–1259.
25. Xiong, M.H., Li, Y.J., Bao, Y., Yang, X.Z., Hu, B., Wang, J., Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv. Mater. 24 (2012), 6175–6180.
26. Meng, Y.S., Hou, X.C., Lei, J.X., Chen, M.M., Cong, S.C., Zhang, Y.Y., Ding, W.M., Li, G.L., Li, X.R., Multi-functional liposomes enhancing target and antibacterial immunity for antimicrobial and anti-biofilm against methicillin-resistant Staphylococcus aureus. Pharm. Res. 33 (2016), 763–775.
27. Zhang, J., Gao, W., Fang, R.H., Dong, A., Zhang, L., Synthesis of nanogels via cell membrane-templated polymerization. Small 11 (2015), 4309–4313.
28. Gao, W., Langer, R., Farokhzad, O.C., Poly(ethylene glycol) with observable shedding. Angew. Chem. Int. Ed. 49 (2010), 6567–6571.
29. Fairbanks, B.D., Schwartz, M.P., Bowman, C.N., Anseth, K.S., Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 30 (2009), 6702–6707.
30. Ma, Y.J., Thiele, J., Abdelmohsen, L., Xu, J.G., Huck, W.T.S., Biocompatible macro-initiators controlling radical retention in microfluidic on-chip photopolymerization of water-in-oil emulsions. Chem. Commun. 50 (2014), 112–114.
31. Hu, C.M.J., Zhang, L., Aryal, S., Cheung, C., Fang, R.H., Zhang, L., Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10980–10985.
32. McGee, M.P., Kreger, A., Leake, E.S., Harshman, S., Toxicity of staphylococcal alpha-toxin for rabbit alveolar macrophages. Infect. Immun. 39 (1983), 439–444.
33. Berube, B.J., Wardenburg, J.B., Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins (Basel) 5 (2013), 1140–1166.
34. Ray, K., Marteyn, B., Sansonetti, P.J., Tang, C.M., Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat. Rev. Microbiol. 7 (2009), 333–340.
35. Hu, C.M.J., Fang, R.H., Wang, K.C., Luk, B.T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C.H., Kroll, A.V., Carpenter, C., Ramesh, M., Qu, V., Patel, S.H., Zhu, J., Shi, W., Hofman, F.M., Chen, T.C., Gao, W.W., Zhang, K., Chien, S., Zhang, L., Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526 (2015), 118–121.
36. Hu, Q.Y., Sun, W.J., Qian, C.G., Wang, C., Bomba, H.N., Gu, Z., Anticancer platelet-mimicking nanovehicles. Adv. Mater. 27 (2015), 7043–7050.
37. Li, Y.M., Liu, G.H., Wang, X.R., Hu, J.M., Liu, S.Y., Enzyme-responsive polymeric vesicles for bacterial-strain-selective delivery of antimicrobial agents. Angew. Chem. Int. Ed. 55 (2016), 1760–1764.